Initially prescribing fewer opioids to be taken over a shorter period decreases the likelihood of chronic use, researchers found.
The Obama administration's cancer "moonshot" could be imperiled by a 19 percent funding cut for the National Institutes of Health.
The PCSK9 inhibitor lowered “bad” cholesterol and the most serious outcomes for heart patients.
Officials in Ohio's Stark County had to borrow a mobile trailer from the state after their morgue reached capacity.
Regulators are called upon to step up their oversight of unapproved stem-cell therapies.
Far fewer new consumers sought coverage for this year through the law's marketplaces, new data show.
"I just started getting short, round and fat,” Mary Clancey, 71, said. She had no idea a growing tumor was threatening her life.
A House bill would allow bosses to ask employees to undergo genetic testing as part of voluntary wellness programs.
The “wrongful birth” bill in the Texas senate has unleashed a heated debate.
Trump's selection for FDA head is likely to shake up the agency but not try to dismantle it.